LASUTH HOLDS SECOND SERIES OF COVID-19 VACCINATION WEBINAR

 LASUTH HOLDS SECOND SERIES OF COVID-19 VACCINATION WEBINAR
The second series of COVID-19 webinar themed “Vaccine Induced Thrombotic Thrombocytopenia” was organized by the Lagos State University Teaching Hospital (LASUTH), held on Saturday, 17th of July, 2021.
In his opening remark, the Chief Medical Director of LASUTH, Prof. Adetokunbo O. Fabamwo acknowledged presence of the Honorable Commissioner for Health, Prof Akin Abayomi, to LASUTH and appreciated him for galvanizing this particular webinar.
Prof. Fabamwo continued his remark by citing a case of vaccine related complication and death of a patient and a few other patients that have been noticed which made the hospital kick off of keeping a record. While speaking, the CMD referred to a literature that cited a group of people who looked at 11 cases in Germany and Austria that developed blood clotting disorder of thrombocytopenia and thrombosis in certain vessels.
He concluded his welcome address by saying that LASUTH is a reputable tertiary centre and “we are on track by organizing such educational webinar, given the account of such cases seen, which is why we have onboard experienced Heamatologists to do justice to the topic”, he said.
While delivering the keynote address, the Honorable Commissioner for Health, Professor Akin Abayomi stated that he was pleased to be part of the continuing effort to understand how COVID-19 is affecting Lagos and Nigeria because of the need to be one step ahead of the virus.
The Commissioner said that the vaccine roll out is in its early stage and only one percent of the target has been achieved, the aim is to hit 60% vaccine induced herd immunity.
He further stated that, in Lagos State, it is important to understand the bio-markers that indicate when something is going wrong, understand how to diagnose and treat it; and also, be in a position to give directives to other doctors and medical communities on how to pick up and not ignore such signs, since there are experiences from observing.
 He finished by saying he is interested in the presentation of the learned Heamatologists on board for the webinar and he is looking forward to a frame work that would be created for the medical community.
While giving case summary of the affected patients, the Director of Clinical Services and Training, Dr. Adebowale Adekoya, briefly detailed the 7 cases of complications resulting from the first and second doses of the COVID-19 vaccines administered in Lagos.
Also speaking on the ‘Epidemiology of Vaccine-Induced Thrombotic Thrombocytopenia’, the Consultant Hematologist, LASUTH, Professor Akinsegun Akinbami gave a broad introduction about the topic and spoke about Pathophysiology and Epidemiology of Vaccine Induced Thrombotic Thrombocytopenia. He explained during his presentation that one should not have blood clot in the veins ordinarily except he is dead but the COVID-19 vaccine can induce blood clot while somebody is alive.
In her presentation, Consultant Hematologist, (LUTH), Dr. Olufunto Kalejaiye spoke on Clinical Features and Evaluation of Vaccine Induced Thrombotic Thrombocytopenia stressing that the condition sets in a patient between 5 to 15 days of vaccination.
Also speaking on the Management and Prevention of Vaccine Induced Thrombotic thrombocytopenia, Consultant Hematologist at the Next Hematology Medicare, Lagos, Dr. Sade Popoola gave insights on how to identify patients who presents with VITT, citing that patient should be asked if they have been vaccinated or not; and that should be part of patients’ history.
The Director of Clinical Services and Training, Dr. Adebowale Adekoya, on behalf of the Chief Medical Director, Prof. Adetokunbo Fabamwo thanked all the speakers and the participants at the webinar assuring them of the continuity of the program.

Ayomide Oyewole

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.